About: http://data.cimple.eu/news-article/993b7f45acc9221726fc8e0db1a59804fac15c60e0112674f67dfc35

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/993b7f45acc9221726fc8e0db1a59804fac15c60e0112674f67dfc35 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	A single-shot Covid-19 vaccine by US drugmaker Johnson and Johnson is likely to be approved for use in the European Union in early March, a French minister said Sunday. The vaccine was cleared for emergency use in the United States on Saturday, becoming the third available vaccine there. The single-shot vaccine is highly effective in preventing severe Covid-19, including against newer variants, the Food and Drug Administration (FDA) said before giving it the green light. French Industry Minister Agnes Pannier-Runacher told France 3 television that the European Medicines Agency (EMA) was also evaluating information transmitted by the US pharmaceuticals company. An EU approval in early March would allow the vaccine to be rolled out in late March or early April, she said, adding this was "good news" because it offers protection with a single shot in contrast to other vaccines requiring two. She said it was possible that a booster shot was needed later "but we can't be sure yet". The EU hoped to receive 600 million doses of the vaccine by the end of June, she said. France has so far vaccinated 1.5 million people, the minister said. By June all 15 million people belonging to the country's most vulnerable population segments will have been vaccinated, she added, acknowledging however that reaching that target might require a faster vaccine rollout. In large clinical trials, the J&J vaccine's efficacy against severe disease was 85.9 percent in the United States, 81.7 percent in South Africa, and 87.6 percent in Brazil. The J&J shot appears less protective than Pfizer and Moderna's two-shot regimens, which both have an efficacy of around 95 percent against all forms of Covid-19 from the classic coronavirus strain. jra/jh/wai
schema:headline	EU to clear Johnson and Johnson vaccine in March: France
schema:mentions	France 3 France national football team Pistol European Medicines Agency Booster dose French language Food and Drug Administration South Africa European Union France Pfizer Brazil Vaccine United States Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-02-28 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	68 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software